Loading clinical trials...
Loading clinical trials...
This purpose of this study is to determine the ability of an 18F-fluoro-L-dihydroxyphenylalanine (18F-DOPA) PET (Positron Emission Tomography) scan to detect a focal lesion of hyperinsulinism and dete...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Children's Hospital of Philadelphia
NCT07585032 · Insulinoma; Pancreas
NCT00001276 · Hypoglycemia, Insulinoma
NCT05945576 · Silver Russell Syndrome, Beckwith-Wiedemann Syndrome, and more
NCT07272187 · Insulinoma; Pancreas, MEN1, and more
NCT02021604 · Congenital Hyperinsulinism, Insulinoma
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions